Filing Details
- Accession Number:
- 0001179110-13-017062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-26 12:13:42
- Reporting Period:
- 2013-11-25
- Filing Date:
- 2013-11-26
- Accepted Time:
- 2013-11-26 12:13:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1345695 | Bruce Leicher | C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142 | Svp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-11-25 | 192 | $17.77 | 108,975 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-11-25 | 12,464 | $18.00 | 108,975 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-11-25 | 836 | $18.00 | 108,975 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to purchase stock | Acquisiton | 2013-11-25 | 12,464 | $10.43 | 12,464 | $10.43 |
| Common Stock | Option to purchase stock | Acquisiton | 2013-11-25 | 836 | $10.43 | 836 | $10.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 205,764 | 2013-02-25 | 2019-02-25 | No | 4 | M | Direct |
| 204,928 | 2013-02-25 | 2019-02-25 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2008.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2013.
Billionaire Hedge Funds
